EMPLOYMENT AGREEMENTEmployment Agreement • July 22nd, 2004 • Cabg Medical Inc • Minnesota
THIS AGREEMENT made this 18th day of August is by and between CABG Medical, Inc., a Minnesota Corporation (the “Company”), and John L. Babitt, a resident of the State of Minnesota (the “Employee”).
MASTER LICENSE AGREEMENTAgreement • November 24th, 2004 • Cabg Medical Inc • Surgical & medical instruments & apparatus • Minnesota
THIS AGREEMENT is by and between SurModics, Inc., a corporation of the State of Minnesota, which has an office at 9924 West 74th Street, Eden Prairie, MN 55344 (hereinafter referred to as SURMODICS), and CABG Medical, Inc., a corporation of Minnesota, which has an office at 14505 21st Avenue North, Suite 212, Minneapolis, MN 55447 (hereinafter referred to as CABG).
Underwriting AgreementUnderwriting Agreement • November 8th, 2004 • Cabg Medical Inc • Surgical & medical instruments & apparatus • Minnesota
The undersigned is or intends to become an owner of record or beneficially of certain shares of Common Stock of the Company (“Common Stock”) or securities convertible into or exchangeable or exercisable for Common Stock.
SUPPLY AGREEMENTSupply Agreement • July 22nd, 2004 • Cabg Medical Inc • Arizona
This Agreement, dated 1/1/04, is made between BARD PERIPHERAL VASCULAR, Inc., a subsidiary of C. R. Bard, Inc. (“Bard”), having offices at 1625 W. 3rd Street, Tempe, AZ 85281 (“BARD PERIPHERAL VASCULAR”) and CABG Medical, Inc., having offices at 14505 21st Ave. N., Suite 212, Minneapolis, MN 55447 (“Purchaser”).
TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • July 22nd, 2004 • Cabg Medical Inc • Minnesota
This Agreement is made as of 5 JUNE, 1996 by and between Manuel A. Villafaña, a Minnesota resident (“Transferee”) and ATS Medical, Inc., a Minnesota corporation (“ATS”).
Clinical Coating AgreementCoating Agreement • July 22nd, 2004 • Cabg Medical Inc
WHEREAS, CABG and SURMODICS are parties to a Mutual Confidential Disclosure Agreement, effective December 27, 2001 that prohibits CABG from using SURMODICS’ coatings in human subjects;
AMENDMENTCabg Medical Inc • October 29th, 2004 • Surgical & medical instruments & apparatus
WHEREAS, the parties are party to that certain Clinical Coating Agreement, effective April 15, 2003 (as amended June 30, 2004, the “Agreement”);
MATERIALS TRANSFER AGREEMENT MAYNE PHARMA (USA) INCMaterials Transfer Agreement • July 22nd, 2004 • Cabg Medical Inc • Minnesota
Mayne Pharma (USA) Inc (“Mayne”) agrees to transfer the materials to CABG Medical, Inc. (“Recipient”) and Recipient agrees to use the Materials to carry out the Research Plan described below on terms and conditions agreed to between the Parties (Mayne and Recipient) and hereinafter appearing:
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • February 13th, 2006 • Cabg Medical Inc • Surgical & medical instruments & apparatus
NOW, THEREFORE, Company and Employee agree that effective as of the date and year written above the following Amendment shall be made a part of the Employment Agreement:
EMPLOYMENT AGREEMENTEmployment Agreement • March 25th, 2005 • Cabg Medical Inc • Surgical & medical instruments & apparatus • Minnesota
THIS AGREEMENT made this 31st day of December, 2004 is by and between CABG Medical, Inc., a Minnesota Corporation (the “Company”), and Manuel A. Villafana, a resident of the State of Minnesota (the “Employee”).
MANUEL A. VILLAFANA CONSULTING AGREEMENTConsulting Agreement • July 22nd, 2004 • Cabg Medical Inc
THIS AGREEMENT is made as of the 1st day of April, 2003 by an between CABG Medical, Inc., a Minnesota corporation (the “Company”), and Manuel A. Villafaña, a resident of the States of Minnesota (“MAV”).
Mr. Manuel A. Villafaña CABG Medical, Inc. 14505 — 21st Avenue North, Suite 212 Minneapolis, MN 55447-5602 Dear Mr. Villafaña:Letter Agreement • March 2nd, 2006 • Cabg Medical Inc • Surgical & medical instruments & apparatus
This letter agreement (“Agreement”) confirms in writing the oral agreement which you and CABG Medical, Inc. entered into on February 24, 2006, regarding your Change of Control Agreement dated June 17, 2003. The terms of this Agreement are as follows:
CABG MEDICAL, INC. INVESTMENT AGREEMENTInvestment Agreement • May 9th, 2005 • Cabg Medical Inc • Surgical & medical instruments & apparatus • Minnesota
This Investment Agreement (the “Agreement”) is made as of March 22, 2005 by and between CABG Medical, Inc., a Minnesota corporation (the “Company”) with its principal office at 14505 21st Avenue North, Minneapolis, Minnesota 55447, and Angiotech Pharmaceuticals, Inc., a corporation organized and existing under the laws of the Province of British Columbia (“Angiotech”) with its principal office at 1618 Station Street, Vancouver, British Columbia, Canada V6A 1B6.
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • March 2nd, 2006 • Cabg Medical Inc • Surgical & medical instruments & apparatus
WHEREAS, the Company and Employee are parties to that certain Employment Agreement dated December 31, 2004 (hereinafter “Employment Agreement”);
LICENSE AGREEMENTLicense Agreement • May 9th, 2005 • Cabg Medical Inc • Surgical & medical instruments & apparatus • Washington
This License Agreement, effective as of March 22, 2005 (the “Effective Date”), is by and between Angiotech Pharmaceuticals, Inc., a corporation organized and existing under the laws of the Province of British Columbia, Canada (“Angiotech Parent”), Angiodevice International GmbH, a corporation organized and existing under the laws of Switzerland (“Angiodevice”), Angiotech International AG, a corporation organized and existing under the laws of Switzerland (“Angiotech International”), Angiotech BioCoatings Corp., a corporation organized and existing under the laws of the State of New York, USA (“Angiotech BioCoatings”) and CABG Medical, Inc., a corporation organized and existing under the laws of the State of Minnesota, USA (“CABG”). Each of the parties hereto is referred to herein as “Party” and collectively as the “Parties”.
TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • July 22nd, 2004 • Cabg Medical Inc • Minnesota
THIS TECHNOLOGY TRANSFER AGREEMENT (the “Agreement”), is entered into effective July 15, 2004, by and between CABG Medical, Inc., a Minnesota corporation (the “Company”) and Manuel A. Villafaña (“Villafaña”).
AMENDMENT to the April 15, 2003 Clinical Coating AgreementCoating Agreement • September 2nd, 2004 • Cabg Medical Inc • Surgical & medical instruments & apparatus
This Amendment to the April 15, 2003 Clinical Coating Agreement (the “Agreement”) is by and between SurModics, Inc. (SURMODICS) and CABG Medical, Inc. (CABG) and shall be effective June 30, 2004.
Re: Amendment to Technology Transfer Agreement between ATS Medical, Inc. and Manuel A. VillafañaCabg Medical Inc • July 22nd, 2004
This letter concerns the Technology Transfer Agreement Dated June 5, 1996 between ATS Medical, Inc. (“ATS”) and Manuel A. Villafaña (the “Agreement”). The purpose of this amendment is to (i) transfer the rights and obligations of Manuel A. Villafaña to CABG Medical, Inc. (“CABG”), (ii) amend the royalty payment provision set forth in Section 2 of the Agreement, and (iii) amend the termination provision set forth in Section 6 of the Agreement.
DISCHARGE AND TERMINATION AGREEMENT REGARDING “CHANGING IN CONTROL” LETTER AGREEMENTDischarge and Termination Agreement • February 13th, 2006 • Cabg Medical Inc • Surgical & medical instruments & apparatus
WHEREAS, Company and Employee are parties to that certain letter agreement dated June 17, 2003 regarding severance benefits due Employee in the event Employee’s employment with Company terminates under certain circumstances subsequent to a “Change in Control” (hereinafter referred to as “Letter Agreement”); and
DISCHARGE AND TERMINATION AGREEMENT REGARDING “CHANGING IN CONTROL” LETTER AGREEMENTDischarge and Termination Agreement • February 13th, 2006 • Cabg Medical Inc • Surgical & medical instruments & apparatus
WHEREAS, Company and Employee are parties to that certain letter agreement dated July 31, 2003 regarding severance benefits due Employee in the event Employee’s employment with Company terminates under certain circumstances subsequent to a “Change in Control” (hereinafter referred to as “Letter Agreement”); and
